Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus SODIUM PHOSPHATES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus SODIUM PHOSPHATES.
CALCIUM GLUCEPTATE vs SODIUM PHOSPHATES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium gluceptate is a calcium salt that dissociates to provide calcium ions, which are essential for various physiological processes including nerve conduction, muscle contraction, blood coagulation, and cardiac function. It acts as a calcium replenisher.
Sodium phosphates act as a source of phosphate and sodium ions. Phosphate is an essential component of bone mineral, cell membranes, and energy metabolism. It also acts as a buffer in acid-base balance. In the gastrointestinal tract, hyperosmotic sodium phosphate solution draws water into the lumen, inducing bowel evacuation.
IV: 2-4 mg/kg elemental calcium (5-10 mL of 0.45 mEq/mL solution) administered slowly over 10-20 minutes. May repeat if needed. Maximum dose: 20 mL per infusion.
Oral: 3.75-7.5 g (15-30 mmol phosphate) 1-4 times daily. IV: 0.3-0.5 mmol/kg over 6-12 hours.
None Documented
None Documented
Terminal elimination half-life: 2-4 hours (normal renal function); prolonged to 12-24 hours in renal impairment.
Not applicable; phosphate is an endogenous ion with rapid equilibration. Serum phosphate half-life is approximately 30 minutes due to renal clearance and cellular uptake.
Renal: >90% excreted unchanged in urine. Biliary/fecal: <5%.
Renal: >90% of absorbed phosphate is excreted renally, primarily as inorganic phosphate; fecal elimination accounts for <10%.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement